406 filings
Page 10 of 21
8-K
iyik38g2a
18 May 06
Alkermes Reports Financial Results for Fiscal Year 2006 and Provides Financial Expectations for Fiscal Year 2007
12:00am
8-K
nsxb9fnw gv
8 May 06
Entry into a Material Definitive Agreement
12:00am
8-K
nrbsmwn0ezjhw6j1i
14 Apr 06
Alkermes and Cephalon Receive Fda Approval of Vivitroltm for the Treatment of Alcohol Dependence
12:00am
CORRESP
t0p5priyc
31 Mar 06
Correspondence with SEC
12:00am
8-K
2d0bd4
7 Mar 06
Regulation FD Disclosure
12:00am
8-K
08jy3w dsj
7 Feb 06
Alkermes Reports Third Quarter Fiscal 2006 Financial Results
12:00am
CORRESP
c6hxujn45e4 dl9g
28 Dec 05
Correspondence with SEC
12:00am
8-K
utap2mf q23h
28 Dec 05
Fda Issues Approvable Letter for Vivitroltm(formerly Vivitrex®), for the Treatment of Alcohol Dependence
12:00am
CORRESP
lq9ssl55 j7ywixxr3pd
5 Dec 05
Correspondence with SEC
12:00am
UPLOAD
azv6hi7 36du84
30 Nov 05
Letter from SEC
12:00am
8-K
h4laksp
3 Nov 05
Alkermes Reports Second Quarter Fiscal 2006 Financial Results
12:00am
8-K
tpnezf4ptjvlf2
31 Oct 05
Regulation FD Disclosure
12:00am
8-K
xduyduuu azw3pvvqo
26 Oct 05
Regulation FD Disclosure
12:00am
CORRESP
r8vwf86c bm8j
21 Oct 05
Correspondence with SEC
12:00am
8-K
514x90280s2 f5p5k
12 Oct 05
Regulation FD Disclosure
12:00am
CORRESP
sfmixm0tws3kep27
30 Sep 05
Correspondence with SEC
12:00am
8-K
1gn ientei
28 Sep 05
Amendments to Articles of Incorporation or Bylaws
12:00am